TORONTO, Nov. 6 /CNW/ - Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced its operational and financial results for the three and six months ended September 30, 2008.
TORONTO, Nov. 6 /CNW/ - Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced its operational and financial results for the three and six months ended September 30, 2008.
